Abstract Clinical use of honey in the topical treatment of wounds has increased in Europe and North America since licensed wound care products became available in 2004 and 2007, respectively. Honey-resistant bacteria have not been isolated from wounds, but there is a need to investigate whether honey has the potential to select for honey resistance. Two cultures of bacteria from reference collections (Staphylococcus aureus NCTC 10017 and Pseudomonas aeruginosa ATCC 27853) and four cultures isolated from wounds (Escherichia coli, methicillin-resistant S. aureus (MRSA), Pseudomonas aeruginosa and S. epidermidis) were exposed to sub-lethal concentrations of manuka honey in continuous and stepwise training experiments to determine whether the susceptibility to honey diminished. Reduced susceptibilities to manuka honey in the test organisms during long-term stepwise resistance training were found, but these changes were not permanent and honey-resistant mutants were not detected. The risk of bacteria acquiring resistance to honey will be low if high concentrations are maintained clinically.
Introduction
For thousands of years, wounds were treated topically with relatively poorly characterised preparations of antimicrobial agents derived from animal, vegetable and mineral sources [1] . Apart from honey, many of those substances were too toxic for internal use [2] . During the 19th century, the chemical industry yielded a variety of antiseptic compounds that were utilised for preventing and treating wound infections [3] , but in recent times, cytotoxicity has limited their acceptance [4] . A systematic strategy of discovering and evaluating promising chemotherapeutic antimicrobial agents was initiated by Paul Ehrlich at the beginning of the 20th century; it paved the way for the advent of antibiotics, which revolutionised the treatment of infection. These antimicrobial agents, with their specific mechanisms of inhibition, exhibited selective toxicity against microbial species rather than patients and were initially effective in controlling infections. Although not universally susceptible to all antibiotics, most microbial species were susceptible to at least one type of antibiotic. To date, 17 classes of antibiotic have been introduced, but the rate of discovery of new antibiotics has slowed within the past 20 years. The therapeutic value of many antibiotics has been curtailed by the acquisition of resistance in species that were once susceptible, as well as the emergence of species with resistance to multiple antibiotics. This is a real concern because species resistant to every known antibiotic have emerged [5] , antiseptic-resistant strains have been isolated and organisms with both antibiotic and antiseptic resistance determinants have been discovered [6] . The speed of emergence of antimicrobial resistance is unpredictable [7] , but whenever a new inhibitory agent is introduced, resistant organisms emerge in due course. With fewer effective antimicrobial agents to manage wound infections, impacts such as increased morbidity, treatment costs and mortalities have ensued [8] . Novel antimicrobial remedies are needed, but there is always the possibility that organisms with resistance to these agents will arise.
Since medical-grade honey was first licensed for treating wounds in Australia in 1999, the clinical use of wound care products containing honey has extended to Canada, Europe, Hong Kong, New Zealand and the United States of America. As with antibiotics, the extensive use of honey may well provide a selective pressure for the emergence of honey-resistant strains of wound pathogens. This can be tested in vitro by either repeated cultivation of bacteria in a sub-lethal concentration of the agent or by incubation in stepwise increasing concentrations. The aim of this study, therefore, was to determine whether bacteria continuously exposed to low concentrations of manuka honey changed their susceptibility to manuka honey and whether resistant strains were selected.
Methods

Organisms tested
In short-term resistance training experiments, Staphylococcus aureus NCTC 10017 and Pseudomonas aeruginosa ATCC 27853 were utilised with a sample of sterile manuka honey provided by the New Zealand Natural Food Company. For the rest of the study, clinical isolates of methicillin-resistant S. aureus (MRSA), S. epidermidis, Escherichia coli and Pseudomonas aeruginosa were tested with a sample of manuka honey that was provided by Comvita UK (Manukacare 18+). This product is available as Medihoney in Canada and the United States. The clinical isolates were cultures of bacteria that had been isolated from patients with chronic wounds attending a local out-patient clinic at the University Hospital of Wales, Cardiff, UK. Using a bioassay [9] , the antibacterial activity of the New Zealand Natural Food Company honey sample was found to be equivalent to 19%(w/v) phenol and Manukacare 18+ was equivalent to 18%(w/v) phenol.
Determination of minimum inhibitory concentrations (MICs)
MICs were determined in 96-well, flat-bottomed microtitre plates (Nunc, Roskilde, Denmark) using manuka honey dissolved in either nutrient broth (NB; Oxoid, Basingstoke, UK) or Iso-Sensitest broth (ISB; Oxoid, Basingstoke, UK). Honey concentrations varying by 1%(w/v) were used in successive wells and all wells contained 200 µl. Wells were inoculated with 1 µl undiluted overnight broth cultures of test organisms (approximately 1×10 6 cfu/ml) and incubated at 37°C for 24 h. Positive (broth and inoculum) and negative controls (broth and honey) were included. The MICs were determined visually and confirmed by measuring the absorbance at 400 nm in a microtitre plate reader (Anthos Labtec Instruments).
Short-term resistance training by exposure to a single sub-lethal concentration of manuka honey
To one 100-ml conical flask with 20 ml NB containing 2.5%(w/v) manuka honey, 40 µl overnight broth culture of S. aureus was inoculated and to another 100-ml conical flask with 20 ml NB containing 8%(w/v) manuka honey, 40 µl P. aeruginosa was inoculated. Both flasks were incubated at 37°C in a shaking water bath (100 cycles per min) for 24 h. On 10 successive days, similar, freshly prepared flasks were inoculated with 40 µl from each preceding days' culture, respectively. The MICs for each test organism were determined on days 0 and 10 and compared by the Mann-Whitney test using Minitab version 14.
Short-term resistance training by exposure to stepwise increasing concentrations of manuka honey Cultures were set up as above using an initial concentration of 1%(w/v) manuka honey in NB for S. aureus and 5%(w/v) manuka honey in NB for P. aeruginosa and incubated at 37°C with shaking for 24 h. At 24-h intervals on 10 consecutive days, freshly prepared broths with honey concentrations increased by 0.5%(w/v) for S. aureus and 1%(w/v) for P. aeruginosa were inoculated with 40 µl from the preceding days' culture. Throughout the training period, the identity of each culture was confirmed daily by BBL Crystal kits (Becton Dickinson, Basingstoke, UK). For both test organisms, the MICs of manuka honey were determined before and after the training period.
Stepwise resistance training of clinical isolates by long-term exposure to sub-inhibitory concentrations of manuka honey The MICs of manuka honey for each of the clinical isolates were determined before continuous exposure to honey. In a 96-well, flat-bottomed microtitre plate for each of the four test organisms, a range of 15 concentrations of manuka honey (Comvita Manukacare 18+) in ISB that varied by 1% (w/v) intervals and included concentrations above and below the initial MIC of each test organism was prepared. Each well contained 200 µL ISB and honey and was inoculated on day 0 with 5 µl overnight broth culture and then incubated at 37°C for 24 h. The MIC was determined visually as the lowest concentration of honey to prevent growth. A fresh microtitre plate was prepared every 24 h with a new range of 15 honey concentrations contained in ISB that increased by 1%(w/v) increments and included the last MIC in the middle of the range. With time, increasingly higher concentrations of honey in ISB were required, but the range always included honey concentrations above and below the expected MIC. On each successive day of the experiment, wells in the new microtitre plate were inoculated with 5 μl of each respective test organism taken from the well of the previous microtitre plate containing the highest concentration of honey with viable cells (i.e. one well below the actual MIC). Also, the purity of each inoculum was checked by dropping 20 μl onto nutrient agar plates and streaking out to achieve isolated colonies after incubation at 37°C for 24 h. The experiment was continued for 28 successive days with each test organism using an appropriate range of honey concentrations above and below the last recorded MIC value. Cultures obtained after 28 days continuous exposure to a sub-lethal concentration of honey were frozen and stored at −80°C for future reference.
Recovery of cultures of clinical isolates following long-term exposure to honey Each 'honey-trained' culture obtained after 28 days continuous exposure to manuka honey was inoculated into 20 ml ISB contained within a 100-ml conical flask and incubated in a shaking water bath at 37°C for 24 h. On each successive day, one of four fresh flasks of ISB were inoculated with 100 μl of each culture transferred from the preceding days' culture, respectively, until 28 days had elapsed. At each daily transfer, the MIC against manuka honey was determined. Cultures obtained after the 28-day recovery period were frozen and stored at −80°C.
Cultural characteristics
The identity of the test organisms before the start of the long-term training regime, collected after the 28-day training period and after the 28-day recovery period, was determined by Crystal kits (Becton Dickinson, Basingstoke, UK) and by random amplified polymorphic DNA (RAPD) typing.
Results
Short-term resistance training with reference cultures
When S. aureus NCTC 10017 was cultured in a sub-lethal concentration of manuka honey for 10 consecutive days, the susceptibility to manuka honey did not decrease significantly (Table 1) . Conversely, the MIC for P. aeruginosa ATCC 27853 increased significantly from 15.7 to 19.7%(w/v), indicating that the culture had become less susceptible to manuka honey. However, after six subcultures in honey-free NB, there was no significant difference in the MIC compared to the starting value.
When these two test organisms were successively cultured in stepwise increasing concentrations of honey, viable bacteria were not recovered above their starting MIC values. Hence, honey resistance was not observed in either S. aureus or P. aeruginosa.
Resistance training of clinical isolates by long-term exposure to honey
The susceptibility of the four clinical isolates tested in this study for manuka honey decreased during the 28-day Mean MIC %(w/v) ± SD (n) Fig. 1 Sensitivity of four clinical isolates to manuka honey during exposure to sub-lethal concentrations of manuka honey for 28 days. The minimum inhibitory concentrations (MICs) of manuka honey in sub-cultures of four clinical isolates during a long-term honey resistance training experiment. Cultures were isolated from patients with chronic wounds: Escherichia coli (triangles), methicillin-resistant Staphylococcus aureus (MRSA) (diamonds), Pseudomonas aeruginosa (circles) and S. epidermidis (squares) resistance training period (Fig. 1) , with the greatest proportional change observed for E. coli (2.1) and the least in P. aeruginosa (1.4). The MICs of MRSA and S. epidermidis increased by factors of 1.6 and 1.7, respectively . However, during the recovery period, the MIC values returned to pretraining values within 9 and 14 days for S. epidermidis and P. aeruginosa, respectively, demonstrating that honey-resistant strains of these bacteria had not been selected (Fig. 2) . Neither MRSA nor E. coli returned to the pre-training MIC values within the 28-day recovery period. Several months later, the cultures frozen at the end of the recovery period were thawed and the MICs were determined in duplicate on three separate occasions ( Table 2 ). Minimum bactericidal concentrations (MBCs) were also determined by streaking out samples from microtitre plate wells, showing no growth onto nutrient agar. It was seen that the susceptibility of three of the clinical isolates was similar to those values obtained before resistance training (Fig. 1) , but the MIC of manuka honey in E. coli remained 1.4 times higher. The MBC values were close to the MICs, indicating that manuka honey was bactericidal for the recovered cultures.
Time (days) MIC %(w/v) manuka honey
It is, perhaps, worth noting that, by exposing each test organism to a range of honey concentrations simultaneously during the long-term training experiment, the MIC values were obtained daily at each transfer step. This meant that only one determination was obtained at each time point. MICs obtained later on stored cultures were done in replicate (Table 2) . Unlike antibiotic testing, where serial doubling dilutions series are normally utilised, here, honey concentrations differing by 1%(w/v) intervals were used to obtain a more precise estimate of the MIC.
Purity plates and biochemical characteristics confirmed that culture identities were maintained throughout the training and recovery periods; the RAPD profiles remained constant.
Discussion
The excessive use and misuse of antibiotics is known to favour the selection of resistant strains and to inhibit sensitive strains. In Norway, for example, where mupirocin was not available, mupirocin-resistant strains of S. aureus were not detected [10] . Restricting mupirocin use in an American medical centre caused an immediate reduction in the occurrence of mupirocin-resistant MRSA [11] and an association between exposure to fusidic acid and fusidic acid resistance in S. aureus has been established [12] . Resistance to biocides used for skin and wound care has also been demonstrated [6] . In the first 'acclimatization' experiments in 1887, reduced sensitivity to mercuric chloride and boric acid was noted [13] ; increased tolerance towards many other antibiotics and antiseptics has since been investigated. The inability to select for resistance to povidone-iodine has been reported [13] , yet, P. stutzeri was shown to develop stable resistance to each of chlorhexidine diacetate and cetylpyridinium chlorine when exposed to stepwise increases in concentration [14] . Bacterial resistance to silver, which is often used in wound care, is well defined and debated [15, 16] . Furthermore, short-term stepwise resistance training of P. aeruginosa ATCC 27853 to each of tetracycline, ciprofloxacin and honey, and of S. aureus ATCC 9144 to each of tetracycline, oxacillin and honey demonstrated the acquisition of antibiotic resistance but not honey resistance [17] . In that study, antibioticresistant strains recovered after stepwise resistance training to antibiotics exhibited antibiotic susceptibilities significantly reduced by factors of 32 and 64 [17] .
Our study showed that continuous exposure to sub-lethal concentrations of manuka honey for up to 28 days failed to select for honey-resistant mutants in any of two reference cultures or four clinical isolates. Reduced susceptibility to manuka honey was observed throughout the long-term training period in each of the clinical isolates. Unlike the large changes in susceptibilities seen in antibiotic resistance training [17] , the honey MICs increased in P. aeruginosa, MRSA, S. epidermidis and E. coli by factors of 1.4, 1.6, 1.7 and 2.1, respectively (Fig. 1) . These changes, however, were not permanent, because susceptibility to honey was found to increase during cultivation in honey-free media and during storage at −80°C. The MICs of final cultures ( Fig. 2 and Table 2 ) were close to the pre-training MIC values ( Fig. 1) , except for E. coli, which remained 1.4 times higher than at the start of the honey resistance training period. It is not known why susceptibility to honey increased in E. coli and MRSA during storage at −80°C. The European consensus of a clinically resistant organism is one in which the level of antimicrobial susceptibility has a high likelihood of clinical failure [18] . Since the concentrations of medicalgrade manuka honey that are contained in contemporary licensed wound care products usually exceed 80% (w/v) and many are 95% (w/v), the honey susceptibilities found in our experiments are not likely to give rise to clinical failure. Topical application of honey to wounds will invariably result in dilution, depending on the extent of exudation, and concentrations in vivo must always exceed those shown to be inhibitory in vitro by a significant margin. Providing that the concentration of manuka honey in practice exceeds the highest MBC recorded here by a factor of three, the risk of selecting honey-resistant organisms should be low. Regular dressing changes will help to keep levels of manuka honey high, particularly in highly exuding wounds. Maintaining high levels of antimicrobial agents in the wound environment is always necessary to effectively inhibit viable bacteria before resistant strains emerge. For some biocides, cytotoxicity may then become a limitation, but this should not be an issue with manuka honey.
Our findings confirm and extend those of Blair et al. [17] . With increasing topical use of honey in wounds, the possibility of selecting for honey-resistant wound pathogens is raised. This study suggests that this outcome will be rare if high concentrations of manuka honey are maintained in clinical practice. Prolonged exposure to antimicrobial agents, including honey, should always be avoided. Hopefully, manuka honey will continue to be used as a whole product and specific active components will not be purified and used alone, because this is more likely to promote the development of honey-resistant bacteria [19] [20] [21] .
